1. Baginskaya, N.V., Ilnitskaya, S.I., Nikitenko, E.V., and Kaledin, V.I., The promoting effect of ortho-aminoazotoluene on hepatocarcinogenesis is accompanied by increased inflammation and proliferative processes in liver tissue and decrease in concentration of free thyroxine in blood, Byul. Eksp. Biol. Med., 2007, vol. 144, no. 12, pp. 672–676.
2. Baginskaya, N.V., Perepechaeva, M.L., Khoshchenko, O.M., and Dushkin, M.I., Influence of ortho-aminoazotoluene on expression of genes PPAR-αa, PPAR-α, RXR-α, and CAR in liver and levels of IL-1β in blood of mice contrast in terms of sensitivity to chemical hepatocarcinogenesis of strains, in Retseptsiya i vnutrikletochnaya signalizatsiya (Reception and Intracellular Signaling), Pushchino, 2009, pp. 1326–1330.
3. Beigneux, A.P., Moser, A.H., Shigenaga, J.K., Grunfeld, C., and Feingold, K.R., Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response, Biochem. Biophys. Res. Commun., 2002, vol. 293, pp. 145–149.
4. Chen, C.J. and Chen, D.S., Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology, Hepatology, 2002, vol. 36, pp. 1046–1049.
5. Cheung, Y.L., Puddicombe, S.M., Gray, T.J., and Ioannides, C., Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity, Carcinogenesis, 1994, vol. 15, pp. 1257–1263.